[rayiner]

But the patent on daraprim expired decades ago. It was a single source drug because there wasn’t enough money in the market for another manufacturer to make a competing alternative. There are something like 8,000 prescriptions a year.

[wpietri]

In which case that sounds like market failure to me, which is another excellent time for regulation. We do this all the time with other "natural monopolies".